Loading...

Currier Judith

Title(s)Professor, Medicine
Phone(310) 794-9668
vCardDownload vCard
    Other Positions
    Title(s)Professor In-Residence, Infectious Diseases

    Title(s)Director, CARE Center

    Title(s)Chief, Infectious Diseases


    Collapse Research 
    Collapse Research Activities and Funding
    Prospective Evaluation of Antiviral Therapy and Cardiac Health
    NIH/NHLBI R01HL095132Sep 25, 2008 - Jun 30, 2014
    Role: Principal Investigator
    Postdoctoral Training in Global AIDS Prevention Research
    NIH/NIMH T32MH080634Jul 1, 2007 - Jun 30, 2022
    Role: Principal Investigator
    UCLA AIDS Prevention and Treatment Clinical Trials Unit
    NIH/NIAID UM1AI069424Feb 1, 2007 - Nov 30, 2020
    Role: Principal Investigator
    UCLA AIDS Prevention and Treatment Clinical Trials Unit
    NIH/NIAID U01AI069424Feb 1, 2007 - Nov 30, 2013
    Role: Principal Investigator
    Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/
    NIH/NIAID UM1AI068636Jun 29, 2006 - Nov 30, 2020
    Role: Co-Principal Investigator
    Optimizing Antiretroviral Therapy in HIV
    NIH/NIAID K24AI056933Aug 1, 2003 - Feb 28, 2014
    Role: Principal Investigator
    STD FACULTY EXPANSION PROGRAM
    CDC/NCHHSTP R30PS921114Mar 1, 2002 - Feb 28, 2007
    Role: Principal Investigator
    AIDS CLINICAL TRIALS UNIT
    NIH/NIAID U01AI027660Jun 30, 1986 - Dec 31, 2006
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Boltz VF, Shao W, Bale MJ, Halvas EK, Luke B, McIntyre JA, Schooley RT, Lockman S, Currier JS, Sawe F, Hogg E, Hughes MD, Kearney MF, Coffin JM, Mellors JW. Linked dual-class HIV resistance mutations are associated with treatment failure. JCI Insight. 2019 Sep 05. PMID: 31487271.
      View in: PubMed
    2. Trevillyan JM, Moser C, Currier JS, Sallam T. Immune Biomarkers in the Prediction of Future Myocardial Infarction in People with HIV. Clin Infect Dis. 2019 Aug 15. PMID: 31414117.
      View in: PubMed
    3. Le CN, Britto P, Brummel SS, Hoffman RM, Li JZ, Flynn PM, Taha TE, Coletti A, Fowler MG, Bosch RJ, Gandhi RT, Klingman KL, Mcintyre JA, Currier JS. Time to viral rebound and safety after antiretroviral treatment interruption in postpartum women compared to men. AIDS. 2019 Aug 01. PMID: 31373919.
      View in: PubMed
    4. Murnane PM, Bacchetti P, Currier JS, Brummel S, Okochi H, Phung N, Louie A, Kuncze K, Hoffman RM, Nematadzira T, Soko DK, Owor M, Saidi F, Flynn PM, Fowler MG, Gandhi M. Tenofovir concentrations in hair strongly predict virologic suppression in breastfeeding women. AIDS. 2019 Aug 01; 33(10):1657-1662. PMID: 31021852.
      View in: PubMed
    5. Feinstein MJ, Hsue PY, Benjamin LA, Bloomfield GS, Currier JS, Freiberg MS, Grinspoon SK, Levin J, Longenecker CT, Post WS. Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association. Circulation. 2019 Jun 03; CIR0000000000000695. PMID: 31154814.
      View in: PubMed
    6. Landovitz RJ, Zangeneh SZ, Chau G, Grinsztejn B, Eron JJ, Dawood H, Magnus M, Liu AY, Panchia R, Hosseinipour MC, Kofron R, Margolis DA, Rinehart A, Adeyeye A, Burns D, McCauley M, Cohen MS, Currier JS. Cabotegravir is Not Associated with Weight Gain in HIV-uninfected Individuals in HPTN 077. Clin Infect Dis. 2019 May 24. PMID: 31125395.
      View in: PubMed
    7. Currier JS, Hsue P. The Role of Inflammation in HIV-associated Atherosclerosis - One Size May Not Fit All. J Infect Dis. 2019 May 11. PMID: 31077267.
      View in: PubMed
    8. El Kamari V, Moser C, Hileman CO, Currier JS, Brown TT, Johnston L, Hunt PW, McComsey GA. Lower Pretreatment Gut Integrity Is Independently Associated With Fat Gain on Antiretroviral Therapy. Clin Infect Dis. 2019 Apr 08; 68(8):1394-1401. PMID: 30137242.
      View in: PubMed
    9. Currier JS, Havlir DV. CROI 2019: complications and coinfections in HIV infection. Top Antivir Med. 2019 Apr; 27(1):34-40. PMID: 31137001.
      View in: PubMed
    10. Gandhi M, Bacchetti P, Ofokotun I, Jin C, Ribaudo HJ, Haas DW, Sheth AN, Horng H, Phung N, Kuncze K, Okochi H, Landovitz RJ, Lennox J, Currier JS. Antiretroviral Concentrations in Hair Strongly Predict Virologic Response in a Large Human Immunodeficiency Virus Treatment-naive Clinical Trial. Clin Infect Dis. 2019 Mar 05; 68(6):1044-1047. PMID: 30184104.
      View in: PubMed
    11. Grinspoon SK, Fitch KV, Overton ET, Fichtenbaum CJ, Zanni MV, Aberg JA, Malvestutto C, Lu MT, Currier JS, Sponseller CA, Waclawiw M, Alston-Smith B, Cooper-Arnold K, Klingman KL, Desvigne-Nickens P, Hoffmann U, Ribaudo HJ, Douglas PS. Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE). Am Heart J. 2019 Jun; 212:23-35. PMID: 30928825.
      View in: PubMed
    12. Bhagwat P, Kapadia SN, Ribaudo HJ, Gulick RM, Currier JS. Racial Disparities in Virologic Failure and Tolerability During Firstline HIV Antiretroviral Therapy. Open Forum Infect Dis. 2019 Feb; 6(2):ofz022. PMID: 30793009.
      View in: PubMed
    13. Velásquez GE, Huaman MA, Powell KR, Cohn SE, Swaminathan S, Outlaw M, Schulte G, McNeil Q, Currier JS, Del Rio C, Castillo-Mancilla J. Outcomes of a Career Development Program for Underrepresented Minority Investigators in the AIDS Clinical Trials Group. Open Forum Infect Dis. 2019 Mar; 6(3):ofz069. PMID: 30895207.
      View in: PubMed
    14. Hoffman RM, Brummel SS, Britto P, Pilotto JH, Masheto G, Aurpibul L, Joao E, Purswani MU, Buschur S, Pierre MF, Coletti A, Chakhtoura N, Klingman KL, Currier JS. Adverse Pregnancy Outcomes Among Women Who Conceive on Antiretroviral Therapy. Clin Infect Dis. 2019 Jan 07; 68(2):273-279. PMID: 29868833.
      View in: PubMed
    15. Stein JH, Yeh E, Weber JM, Korcarz C, Ridker PM, Tawakol A, Hsue PY, Currier JS, Ribaudo H, Mitchell CKC. Brachial Artery Echogenicity and Grayscale Texture Changes in HIV-Infected Individuals Receiving Low-Dose Methotrexate. Arterioscler Thromb Vasc Biol. 2018 Dec; 38(12):2870-2878. PMID: 30571173.
      View in: PubMed
    16. Hoffman RM, Angelidou KN, Brummel SS, Saidi F, Violari A, Dula D, Mave V, Fairlie L, Theron G, Kamateeka M, Chipato T, Chi BH, Stranix-Chibanda L, Nematadzira T, Moodley D, Bhattacharya D, Gupta A, Coletti A, McIntyre JA, Klingman KL, Chakhtoura N, Shapiro DE, Fowler MG, Currier JS. Maternal health outcomes among HIV-infected breastfeeding women with high CD4 counts: results of a treatment strategy trial. HIV Clin Trials. 2018 12; 19(6):209-224. PMID: 30890061.
      View in: PubMed
    17. Bhagwat P, Ofotokun I, McComsey GA, Brown TT, Moser C, Sugar CA, Currier JS. Changes in Waist Circumference in HIV-Infected Individuals Initiating a Raltegravir or Protease Inhibitor Regimen: Effects of Sex and Race. Open Forum Infect Dis. 2018 Nov; 5(11):ofy201. PMID: 30465010.
      View in: PubMed
    18. Hsue PY, Ribaudo HJ, Deeks SG, Bell T, Ridker PM, Fichtenbaum C, Daar ES, Havlir D, Yeh E, Tawakol A, Lederman M, Currier JS, Stein JH. Safety and Impact of Low-Dose Methotrexate on Endothelial Function and Inflammation in Individuals with Treated Human Immunodeficiency Virus: AIDS Clinical Trials Group Study A5314. Clin Infect Dis. 2018 Sep 14. PMID: 30219823.
      View in: PubMed
    19. Stringer EM, Kendall MA, Lockman S, Campbell TB, Nielsen-Saines K, Sawe F, Cu-Uvin S, Wu X, Currier JS. Pregnancy outcomes among HIV-infected women who conceived on antiretroviral therapy. PLoS One. 2018; 13(7):e0199555. PMID: 30020964.
      View in: PubMed
    20. Kelesidis T, Moser CB, Johnston E, Stein JH, Dube MP, Yang OO, McComsey GA, Currier JS, Brown TT. Brief Report: Changes in Plasma RANKL-Osteoprotegerin in a Prospective, Randomized Clinical Trial of Initial Antiviral Therapy: A5260s. J Acquir Immune Defic Syndr. 2018 07 01; 78(3):362-366. PMID: 29533303.
      View in: PubMed
    21. Morales Rodriguez K, Khalili J, Trevillyan J, Currier J. What Is the Best Model for HIV Primary Care? Assessing the Influence of Provider Type on Outcomes of Chronic Comorbidities in HIV Infection. J Infect Dis. 2018 06 20; 218(2):337-339. PMID: 29481635.
      View in: PubMed
    22. Kelesidis T, Kendall MA, Danoff A, Aberg JA, Currier JS, Schmidt AM. Soluble levels of receptor for advanced glycation endproducts and dysfunctional high-density lipoprotein in persons infected with human immunodeficiency virus: ACTG NWCS332. Medicine (Baltimore). 2018 Jun; 97(22):e10955. PMID: 29851842.
      View in: PubMed
    23. Offor O, Utay N, Reynoso D, Somasunderam A, Currier J, Lake J. Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy. PLoS One. 2018; 13(5):e0196395. PMID: 29746485.
      View in: PubMed
    24. Utay NS, Kitch DW, Yeh E, Fichtenbaum CJ, Lederman MM, Estes JD, Deleage C, Magyar C, Nelson SD, Klingman KL, Bastow B, Luque AE, McComsey GA, Douek DC, Currier JS, Lake JE. Telmisartan Therapy Does Not Improve Lymph Node or Adipose Tissue Fibrosis More Than Continued Antiretroviral Therapy Alone. J Infect Dis. 2018 05 05; 217(11):1770-1781. PMID: 29401318.
      View in: PubMed
    25. Currier JS, Havlir DV. CROI 2018: Complications of HIV Infection and Antiretroviral Therapy. Top Antivir Med. 2018 May; 26(1):22-29. PMID: 29727294.
      View in: PubMed
    26. Rough K, Seage GR, Williams PL, Hernandez-Diaz S, Huo Y, Chadwick EG, Currier JS, Hoffman RM, Barr E, Shapiro DE, Patel K. Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine. N Engl J Med. 2018 04 26; 378(17):1593-1603. PMID: 29694825.
      View in: PubMed
    27. Currier JS. Management of Long-Term Complications of HIV Disease: Focus on Cardiovascular Disease. Top Antivir Med. 2018 Apr; 25(4):133-137. PMID: 29689541.
      View in: PubMed
    28. Phung N, Kuncze K, Okochi H, Louie A, Benet LZ, Ofokotun I, Haas DW, Currier JS, Chawana TD, Sheth AN, Bacchetti P, Gandhi M, Horng H. Development and validation of an assay to analyze atazanavir in human hair via liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2018 Mar 15; 32(5):431-441. PMID: 29315954.
      View in: PubMed
    29. Seang S, Kelesidis T, Huynh D, Park S, Moe AA, Currier JS, Lake JE. Low Levels of Endothelial Progenitor Cells and Their Association with Systemic Inflammation and Monocyte Activation in Older HIV-Infected Men. AIDS Res Hum Retroviruses. 2018 01; 34(1):39-45. PMID: 29226690.
      View in: PubMed
    30. Benson CA, Currier JS, Del Rio C, Gallant JE, Gulick RM, Marrazzo JM, Richman DD, Saag MS, Schooley RT, Volberding PA. A Conversation Among the IAS-USA Board of Directors: Hot Topics and Emerging Data in HIV Research and Care. Top Antivir Med. 2017 Dec/Jan; 24(4):142-151. PMID: 28208122.
      View in: PubMed
    31. Braun HM, Candelario J, Hanlon CL, Segura ER, Clark JL, Currier JS, Lake JE. Transgender Women Living with HIV Frequently Take Antiretroviral Therapy and/or Feminizing Hormone Therapy Differently Than Prescribed Due to Drug-Drug Interaction Concerns. LGBT Health. 2017 10; 4(5):371-375. PMID: 28876170.
      View in: PubMed
    32. Erlandson KM, Fiorillo S, Masawi F, Scherzinger A, McComsey GA, Lake JE, Stein JH, Currier JS, Brown TT. Antiretroviral initiation is associated with increased skeletal muscle area and fat content. AIDS. 2017 08 24; 31(13):1831-1838. PMID: 28590329.
      View in: PubMed
    33. Butt AA, Yan P, Chew KW, Currier J, Corey K, Chung RT, Shuaib A, Abou-Samra AB, Butler J, Freiberg MS. Risk of Acute Myocardial Infarction Among Hepatitis C Virus (HCV)-Positive and HCV-Negative Men at Various Lipid Levels: Results From ERCHIVES. Clin Infect Dis. 2017 Aug 15; 65(4):557-565. PMID: 28444148.
      View in: PubMed
    34. Kelesidis T, Oda MN, Borja MS, Yee Y, Ng KF, Huynh D, Elashoff D, Currier JS. Predictors of Impaired HDL Function in HIV-1 Infected Compared to Uninfected Individuals. J Acquir Immune Defic Syndr. 2017 07 01; 75(3):354-363. PMID: 28346318.
      View in: PubMed
    35. Twigg HL, Crystal R, Currier J, Ridker P, Berliner N, Kiem HP, Rutherford G, Zou S, Glynn S, Wong R, Peprah E, Engelgau M, Creazzo T, Colombini-Hatch S, Caler E. Refining Current Scientific Priorities and Identifying New Scientific Gaps in HIV-Related Heart, Lung, Blood, and Sleep Research. AIDS Res Hum Retroviruses. 2017 Sep; 33(9):889-897. PMID: 28530113.
      View in: PubMed
    36. Chew KW, Liu CY, Ambale-Venkatesh B, Liao D, Horwich TB, Lima JAC, Bluemke DA, Paul Finn J, Butt AA, Currier JS. Subclinical myocardial disease by cardiac magnetic resonance imaging and spectroscopy in healthy HIV/Hepatitis C virus-coinfected persons. J Int Med Res. 2017 Dec; 45(6):1693-1707. PMID: 28606026.
      View in: PubMed
    37. Lake JE, Stanley TL, Apovian CM, Bhasin S, Brown TT, Capeau J, Currier JS, Dube MP, Falutz J, Grinspoon SK, Guaraldi G, Martinez E, McComsey GA, Sattler FR, Erlandson KM. Practical Review of Recognition and Management of Obesity and Lipohypertrophy in Human Immunodeficiency Virus Infection. Clin Infect Dis. 2017 May 15; 64(10):1422-1429. PMID: 28329372.
      View in: PubMed
    38. Currier JS, Britto P, Hoffman RM, Brummel S, Masheto G, Joao E, Santos B, Aurpibul L, Losso M, Pierre MF, Weinberg A, Gnanashanmugam D, Chakhtoura N, Klingman K, Browning R, Coletti A, Mofenson L, Shapiro D, Pilotto J. Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 = 400 cells/mm3. PLoS One. 2017; 12(5):e0176009. PMID: 28489856.
      View in: PubMed
    39. Currier JS, Havlir DV. CROI 2017: Complications and Comorbidities of HIV Disease and Its Treatment. Top Antivir Med. 2017 May/Jun; 25(2):77-83. PMID: 28598792.
      View in: PubMed
    40. Hoffman RM, Phiri K, Parent J, Grotts J, Elashoff D, Kawale P, Yeatman S, Currier JS, Schooley A. Factors associated with retention in Option B+ in Malawi: a case control study. J Int AIDS Soc. 2017 Apr 27; 20(1):21464. PMID: 28453243.
      View in: PubMed
    41. Bhagwat P, Ofotokun I, McComsey GA, Brown TT, Moser C, Sugar CA, Currier JS. Changes in abdominal fat following antiretroviral therapy initiation in HIV-infected individuals correlate with waist circumference and self-reported changes. Antivir Ther. 2017; 22(7):577-586. PMID: 28248190.
      View in: PubMed
    42. Zanni MV, Fitch K, Rivard C, Sanchez L, Douglas PS, Grinspoon S, Smeaton L, Currier JS, Looby SE. Follow YOUR Heart: development of an evidence-based campaign empowering older women with HIV to participate in a large-scale cardiovascular disease prevention trial. HIV Clin Trials. 2017 03; 18(2):83-91. PMID: 28277924.
      View in: PubMed
    43. Landovitz RJ, Tran TT, Cohn SE, Ofotokun I, Godfrey C, Kuritzkes DR, Lennox JL, Currier JS, Ribaudo HJ. HIV Transmission Risk Behavior in a Cohort of HIV-Infected Treatment-Naïve Men and Women in the United States. AIDS Behav. 2016 12; 20(12):2983-2995. PMID: 26979419.
      View in: PubMed
    44. Kelesidis T, Jackson N, McComsey GA, Wang X, Elashoff D, Dube MP, Brown TT, Yang OO, Stein JH, Currier JS. Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection. AIDS. 2016 11 13; 30(17):2625-2633. PMID: 27603288.
      View in: PubMed
    45. Fowler MG, Qin M, Fiscus SA, Currier JS, Flynn PM, Chipato T, McIntyre J, Gnanashanmugam D, Siberry GK, Coletti AS, Taha TE, Klingman KL, Martinson FE, Owor M, Violari A, Moodley D, Theron GB, Bhosale R, Bobat R, Chi BH, Strehlau R, Mlay P, Loftis AJ, Browning R, Fenton T, Purdue L, Basar M, Shapiro DE, Mofenson LM. Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention. N Engl J Med. 2016 11 03; 375(18):1726-1737. PMID: 27806243.
      View in: PubMed
    46. Mathad JS, Gupte N, Balagopal A, Asmuth D, Hakim J, Santos B, Riviere C, Hosseinipour M, Sugandhavesa P, Infante R, Pillay S, Cardoso SW, Mwelase N, Pawar J, Berendes S, Kumarasamy N, Andrade BB, Campbell TB, Currier JS, Cohn SE, Gupta A. Sex-Related Differences in Inflammatory and Immune Activation Markers Before and After Combined Antiretroviral Therapy Initiation. J Acquir Immune Defic Syndr. 2016 10 01; 73(2):123-9. PMID: 27258230.
      View in: PubMed
    47. Lake JE, Seang S, Kelesidis T, Currier JS, Yang OO. Telmisartan increases vascular reparative capacity in older HIV-infected adults: a pilot study. HIV Clin Trials. 2016 11; 17(6):225-232. PMID: 27658740.
      View in: PubMed
    48. Kelesidis T, Tran TTT, Brown TT, Moser C, Ribaudo HJ, Dube MP, Yang OO, McComsey GA, Stein JH, Currier JS. Changes in plasma levels of oxidized lipoproteins and lipoprotein subfractions with atazanavir-, raltegravir-, darunavir-based initial antiviral therapy and associations with common carotid artery intima-media thickness: ACTG 5260s. Antivir Ther. 2017; 22(2):113-126. PMID: 27661466.
      View in: PubMed
    49. Dirajlal-Fargo S, Moser C, Brown TT, Kelesidis T, Dube MP, Stein JH, Currier J, McComsey GA. Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s. Open Forum Infect Dis. 2016 Sep; 3(3):ofw174. PMID: 27704026.
      View in: PubMed
    50. Diaz CM, Segura ER, Luz PM, Clark JL, Ribeiro SR, De Boni R, Eksterman L, Moreira R, Currier JS, Veloso VG, Grinsztejn B, Lake JE. Traditional and HIV-specific risk factors for cardiovascular morbidity and mortality among HIV-infected adults in Brazil: a retrospective cohort study. BMC Infect Dis. 2016 Aug 08; 16:376. PMID: 27503230.
      View in: PubMed
    51. Danoff A, Kendall MA, Currier JS, Kelesidis T, Schmidt AM, Aberg JA. Soluble Levels of Receptor for Advanced Glycation Endproducts (RAGE) and Progression of Atherosclerosis in Individuals Infected with Human Immunodeficiency Virus: ACTG NWCS 332. Inflammation. 2016 Aug; 39(4):1354-62. PMID: 27216802.
      View in: PubMed
    52. Yang OO, Currier JS. Reimann's "Habitual Hyperthermia" Responding to Hormone Therapy. Open Forum Infect Dis. 2016 Sep; 3(3):ofw127. PMID: 27800522.
      View in: PubMed
    53. Kelesidis T, Moser C, Stein JH, Brown TT, Tran TT, Ribaudo HJ, Dube MP, Yang OO, Currier JS, McComsey GA. Changes in Markers of T-Cell Senescence and Exhaustion With Atazanavir-, Raltegravir-, and Darunavir-Based Initial Antiviral Therapy: ACTG 5260s. J Infect Dis. 2016 09 01; 214(5):748-52. PMID: 27354367.
      View in: PubMed
    54. Currier JS, Lockman S. Making waves: safety and efficacy of ART in women. Lancet HIV. 2016 09; 3(9):e398-e399. PMID: 27562733.
      View in: PubMed
    55. Havlir DV, Currier JS. CROI 2016: Complications of HIV Infection and Antiretroviral Therapy. Top Antivir Med. 2016 May-Jun; 24(1):38-46. PMID: 27398861.
      View in: PubMed
    56. Hanna DB, Guo M, Bužková P, Miller TL, Post WS, Stein JH, Currier JS, Kronmal RA, Freiberg MS, Bennett SN, Shikuma CM, Anastos K, Li Y, Tracy RP, Hodis HN, Delaney JA, Kaplan RC. HIV Infection and Carotid Artery Intima-media Thickness: Pooled Analyses Across 5 Cohorts of the NHLBI HIV-CVD Collaborative. Clin Infect Dis. 2016 07 15; 63(2):249-56. PMID: 27118787.
      View in: PubMed
    57. Wagner GJ, Linnemayr S, Ghosh-Dastidar B, Currier JS, Hoffman R, Schneider S. Supporting Treatment Adherence Readiness through Training (START) for patients with HIV on antiretroviral therapy: study protocol for a randomized controlled trial. Trials. 2016 Mar 24; 17:162. PMID: 27009061.
      View in: PubMed
    58. McComsey GA, Moser C, Currier J, Ribaudo HJ, Paczuski P, Dubé MP, Kelesidis T, Rothenberg J, Stein JH, Brown TT. Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors: ACTG A5260s. Clin Infect Dis. 2016 Apr 01; 62(7):853-62. PMID: 26797215.
      View in: PubMed
    59. Lederman MM, Cannon PM, Currier JS, June CH, Kiem HP, Kuritzkes DR, Lewin SR, Margolis DM, McCune JM, Mellors JW, Schacker TW, Sekaly RP, Tebas P, Walker BD, Douek DC. A Cure for HIV Infection: "Not in My Lifetime" or "Just Around the Corner"? Pathog Immun. 2016; 1(1):154-164. PMID: 27668293.
      View in: PubMed
    60. Hoffman RM, Lake JE, Wilhalme HM, Tseng CH, Currier JS. Vitamin D Levels and Markers of Inflammation and Metabolism in HIV-Infected Individuals on Suppressive Antiretroviral Therapy. AIDS Res Hum Retroviruses. 2016 Mar; 32(3):247-54. PMID: 26569649.
      View in: PubMed
    61. Cillo AR, Hilldorfer BB, Lalama CM, McKinnon JE, Coombs RW, Tenorio AR, Fox L, Gandhi RT, Ribaudo H, Currier JS, Gulick RM, Wilkin TJ, Mellors JW. Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery. AIDS. 2015 Oct 23; 29(16):2121-9. PMID: 26544577.
      View in: PubMed
    62. Lake JE, Seang S, Kelesidis T, Liao DH, Hodis HN, Stein JH, Currier JS. Telmisartan to reduce cardiovascular risk in older HIV-infected adults: a pilot study. HIV Clin Trials. 2015 Oct; 16(5):197-206. PMID: 26360501.
      View in: PubMed
    63. Stein JH, Ribaudo HJ, Hodis HN, Brown TT, Tran TT, Yan M, Brodell EL, Kelesidis T, McComsey GA, Dube MP, Murphy RL, Currier JS. A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness. AIDS. 2015 Sep 10; 29(14):1775-83. PMID: 26372383.
      View in: PubMed
    64. Coelho L, Cardoso SW, Luz PM, Hoffman RM, Mendonça L, Veloso VG, Currier JS, Grinsztejn B, Lake JE. Vitamin D3 supplementation in HIV infection: effectiveness and associations with antiretroviral therapy. Nutr J. 2015 Aug 18; 14:81. PMID: 26283663.
      View in: PubMed
    65. Vardhanabhuti S, Ribaudo HJ, Landovitz RJ, Ofotokun I, Lennox JL, Currier JS, Olson LM, Haas DW. Screening for UGT1A1 Genotype in Study A5257 Would Have Markedly Reduced Premature Discontinuation of Atazanavir for Hyperbilirubinemia. Open Forum Infect Dis. 2015 Sep; 2(3):ofv085. PMID: 26180834.
      View in: PubMed
    66. Hoffman RM, Jaycocks A, Vardavas R, Wagner G, Lake JE, Mindry D, Currier JS, Landovitz RJ. Benefits of PrEP as an Adjunctive Method of HIV Prevention During Attempted Conception Between HIV-uninfected Women and HIV-infected Male Partners. J Infect Dis. 2015 Nov 15; 212(10):1534-43. PMID: 26092856.
      View in: PubMed
    67. Thio CL, Smeaton L, Hollabaugh K, Saulynas M, Hwang H, Saravanan S, Kulkarni S, Hakim J, Nyirenda M, Iqbal HS, Lalloo UG, Campbell TB, Lockman S, Currier JS. Comparison of HBV-active HAART regimens in an HIV-HBV multinational cohort: outcomes through 144 weeks. AIDS. 2015 Jun 19; 29(10):1173-82. PMID: 26035319.
      View in: PubMed
    68. Dubé MP, Komarow L, Fichtenbaum CJ, Cadden JJ, Overton ET, Hodis HN, Currier JS, Stein JH. Extended-Release Niacin Versus Fenofibrate in HIV-Infected Participants With Low High-Density Lipoprotein Cholesterol: Effects on Endothelial Function, Lipoproteins, and Inflammation. Clin Infect Dis. 2015 Sep 01; 61(5):840-9. PMID: 25979307.
      View in: PubMed
    69. Lake JE, Hoffman RM, Tseng CH, Wilhalme HM, Adams JS, Currier JS. Success of Standard Dose Vitamin D Supplementation in Treated Human Immunodeficiency Virus Infection. Open Forum Infect Dis. 2015 Apr; 2(2):ofv068. PMID: 26125033.
      View in: PubMed
    70. Chew KW, Bhattacharya D, McGinnis KA, Horwich TB, Tseng CH, Currier JS, Butt AA. Short Communication: Coronary Heart Disease Risk by Framingham Risk Score in Hepatitis C and HIV/Hepatitis C-Coinfected Persons. AIDS Res Hum Retroviruses. 2015 Jul; 31(7):718-22. PMID: 25858663.
      View in: PubMed
    71. Brown TT, Moser C, Currier JS, Ribaudo HJ, Rothenberg J, Kelesidis T, Yang O, Dubé MP, Murphy RL, Stein JH, McComsey GA. Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir. J Infect Dis. 2015 Oct 15; 212(8):1241-9. PMID: 25948863.
      View in: PubMed
    72. Lake JE, McComsey GA, Hulgan T, Wanke CA, Mangili A, Walmsley SL, Currier JS. Switch to Raltegravir From Protease Inhibitor or Nonnucleoside Reverse-Transcriptase Inhibitor Does not Reduce Visceral Fat In Human Immunodeficiency Virus-Infected Women With Central Adiposity. Open Forum Infect Dis. 2015 Apr; 2(2):ofv059. PMID: 26380350.
      View in: PubMed
    73. Kelesidis T, Tran TT, Stein JH, Brown TT, Moser C, Ribaudo HJ, Dube MP, Murphy R, Yang OO, Currier JS, McComsey GA. Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s. Clin Infect Dis. 2015 Aug 15; 61(4):651-60. PMID: 25904376.
      View in: PubMed
    74. Shivakoti R, Yang WT, Gupte N, Berendes S, Rosa AL, Cardoso SW, Mwelase N, Kanyama C, Pillay S, Samaneka W, Riviere C, Sugandhavesa P, Santos B, Poongulali S, Tripathy S, Bollinger RC, Currier JS, Tang AM, Semba RD, Christian P, Campbell TB, Gupta A. Concurrent Anemia and Elevated C-Reactive Protein Predicts HIV Clinical Treatment Failure, Including Tuberculosis, After Antiretroviral Therapy Initiation. Clin Infect Dis. 2015 Jul 01; 61(1):102-10. PMID: 25828994.
      View in: PubMed
    75. Ofotokun I, Na LH, Landovitz RJ, Ribaudo HJ, McComsey GA, Godfrey C, Aweeka F, Cohn SE, Sagar M, Kuritzkes DR, Brown TT, Patterson KB, Para MF, Leavitt RY, Villasis-Keever A, Baugh BP, Lennox JL, Currier JS. Comparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257. Clin Infect Dis. 2015 06 15; 60(12):1842-51. PMID: 25767256.
      View in: PubMed
    76. Havlir DV, Currier JS. CROI 2015: Complications of HIV Infection and Antiretroviral Therapy. Top Antivir Med. 2015 Mar-Apr; 23(1):56-65. PMID: 25965312.
      View in: PubMed
    77. Shah MR, Cook N, Wong R, Hsue P, Ridker P, Currier J, Shurin S. Stimulating high impact HIV-related cardiovascular research: recommendations from a multidisciplinary NHLBI Working Group on HIV-related heart, lung, and blood disease. J Am Coll Cardiol. 2015 Feb 24; 65(7):738-44. PMID: 25677433.
      View in: PubMed
    78. Chew KW, Hua L, Bhattacharya D, Butt AA, Bornfleth L, Chung RT, Andersen JW, Currier JS. The effect of hepatitis C virologic clearance on cardiovascular disease biomarkers in human immunodeficiency virus/hepatitis C virus coinfection. Open Forum Infect Dis. 2014 Dec; 1(3):ofu104. PMID: 25734172.
      View in: PubMed
    79. Kelesidis T, Roberts CK, Huynh D, Martínez-Maza O, Currier JS, Reddy ST, Yang OO. A high throughput biochemical fluorometric method for measuring lipid peroxidation in HDL. PLoS One. 2014; 9(11):e111716. PMID: 25368900.
      View in: PubMed
    80. Cheng QJ, Engelage EM, Grogan TR, Currier JS, Hoffman RM. Who Provides Primary Care? An Assessment of HIV Patient and Provider Practices and Preferences. J AIDS Clin Res. 2014 Nov; 5(11). PMID: 25914854.
      View in: PubMed
    81. Lennox JL, Landovitz RJ, Ribaudo HJ, Ofotokun I, Na LH, Godfrey C, Kuritzkes DR, Sagar M, Brown TT, Cohn SE, McComsey GA, Aweeka F, Fichtenbaum CJ, Presti RM, Koletar SL, Haas DW, Patterson KB, Benson CA, Baugh BP, Leavitt RY, Rooney JF, Seekins D, Currier JS. Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial. Ann Intern Med. 2014 Oct 07; 161(7):461-71. PMID: 25285539.
      View in: PubMed
    82. Kalayjian RC, Wu K, Evans S, Clifford DB, Pallaki M, Currier JS, Smryzynski M. Proteinuria is associated with neurocognitive impairment in antiretroviral therapy treated HIV-infected individuals. J Acquir Immune Defic Syndr. 2014 Sep 01; 67(1):30-5. PMID: 25118793.
      View in: PubMed
    83. Kelesidis T, Currier JS. Dyslipidemia and cardiovascular risk in human immunodeficiency virus infection. Endocrinol Metab Clin North Am. 2014 Sep; 43(3):665-84. PMID: 25169560.
      View in: PubMed
    84. Kelesidis T, Currier JS, Yang OO, Brown TT. Role of RANKL-RANK/osteoprotegerin pathway in cardiovascular and bone disease associated with HIV infection. AIDS Rev. 2014 Jul-Sep; 16(3):123-33. PMID: 25102334.
      View in: PubMed
    85. Asmelash A, Zheng Y, Kaloustian KW, Shaffer D, Sawe F, Ogwu A, Salata R, Currier J, Hughes MD, Lockman S. Predictors of suboptimal CD4 response among women achieving virologic suppression in a randomized antiretroviral treatment trial, Africa. BMC Infect Dis. 2014 Jun 17; 14:331. PMID: 24938526.
      View in: PubMed
    86. Hulgan T, Boger MS, Liao DH, McComsey GA, Wanke CA, Mangili A, Walmsley SL, McCreath H, Milne GL, Sanchez SC, Currier JS, Lake JE. Urinary eicosanoid metabolites in HIV-infected women with central obesity switching to raltegravir: an analysis from the women, integrase, and fat accumulation trial. Mediators Inflamm. 2014; 2014:803095. PMID: 24991090.
      View in: PubMed
    87. Shaffer D, Hughes MD, Sawe F, Bao Y, Moses A, Hogg E, Lockman S, Currier J. Cardiovascular disease risk factors in HIV-infected women after initiation of lopinavir/ritonavir- and nevirapine-based antiretroviral therapy in Sub-Saharan Africa: A5208 (OCTANE). J Acquir Immune Defic Syndr. 2014 Jun 01; 66(2):155-63. PMID: 24562349.
      View in: PubMed
    88. Zheng Y, Hughes MD, Lockman S, Benson CA, Hosseinipour MC, Campbell TB, Gulick RM, Daar ES, Sax PE, Riddler SA, Haubrich R, Salata RA, Currier JS. Antiretroviral therapy and efficacy after virologic failure on first-line boosted protease inhibitor regimens. Clin Infect Dis. 2014 Sep 15; 59(6):888-96. PMID: 24842909.
      View in: PubMed
    89. Mwafongo A, Nkanaunena K, Zheng Y, Hogg E, Samaneka W, Mulenga L, Siika A, Currier J, Lockman S, Hughes MD, Hosseinipour M. Renal events among women treated with tenofovir/emtricitabine in combination with either lopinavir/ritonavir or nevirapine. AIDS. 2014 May 15; 28(8):1135-42. PMID: 24445367.
      View in: PubMed
    90. Luetkemeyer AF, Havlir DV, Currier JS. CROI 2014: Viral hepatitis and complications of HIV disease and antiretroviral therapy. Top Antivir Med. 2014 May; 22(2):602-15. PMID: 24901886.
      View in: PubMed
    91. Stein JH, Currier JS, Hsue PY. Arterial disease in patients with human immunodeficiency virus infection: what has imaging taught us? JACC Cardiovasc Imaging. 2014 May; 7(5):515-25. PMID: 24831212.
      View in: PubMed
    92. Currier JS, Stein JH. HIV and atherosclerosis: moving from associations to mechanisms and interventions. Ann Intern Med. 2014 Apr 01; 160(7):509-10. PMID: 24687073.
      View in: PubMed
    93. Russell ES, Mohammed T, Smeaton L, Jorowe B, MacLeod IJ, Hoffman RM, Currier JS, Moyo S, Essex M, Lockman S. Immune activation markers in peripartum women in Botswana: association with feeding strategy and maternal morbidity. PLoS One. 2014; 9(3):e89928. PMID: 24657960.
      View in: PubMed
    94. Zanni MV, Kelesidis T, Fitzgerald ML, Lo J, Abbara S, Wai B, Marmarelis E, Hernandez NJ, Yang OO, Currier JS, Grinspoon SK. HDL redox activity is increased in HIV-infected men in association with macrophage activation and non-calcified coronary atherosclerotic plaque. Antivir Ther. 2014; 19(8):805-811. PMID: 24535655.
      View in: PubMed
    95. Lake JE, Currier JS. Metabolic disease in HIV infection. Lancet Infect Dis. 2013 Nov; 13(11):964-75. PMID: 24156897.
      View in: PubMed
    96. Hoffman RM, Leister E, Kacanek D, Shapiro DE, Read JS, Bryson Y, Currier JS. Biomarkers from late pregnancy to 6 weeks postpartum in HIV-infected women who continue versus discontinue antiretroviral therapy after delivery. J Acquir Immune Defic Syndr. 2013 Aug 15; 63(5):593-601. PMID: 23714738.
      View in: PubMed
    97. Brown TT, Chen Y, Currier JS, Ribaudo HJ, Rothenberg J, Dubé MP, Murphy R, Stein JH, McComsey GA. Body composition, soluble markers of inflammation, and bone mineral density in antiretroviral therapy-naive HIV-1-infected individuals. J Acquir Immune Defic Syndr. 2013 Jul 01; 63(3):323-30. PMID: 23591634.
      View in: PubMed
    98. Squires K, Feinberg J, Bridge DA, Currier J, Ryan R, Seyedkazemi S, Dayaram YK, Mrus J. Insights on GRACE (Gender, Race, And Clinical Experience) from the patient's perspective: GRACE participant survey. AIDS Patient Care STDS. 2013 Jun; 27(6):352-62. PMID: 23701200.
      View in: PubMed
    99. Luetkemeyer AF, Havlir DV, Currier JS. CROI 2013: Complications of HIV disease, viral hepatitis, and antiretroviral therapy. Top Antivir Med. 2013 Apr-May; 21(2):62-74. PMID: 23681961.
      View in: PubMed
    100. Stein JH, Brown TT, Ribaudo HJ, Chen Y, Yan M, Lauer-Brodell E, McComsey GA, Dubé MP, Murphy RL, Hodis HN, Currier JS. Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infection. AIDS. 2013 Mar 27; 27(6):929-37. PMID: 23196938.
      View in: PubMed
    101. Lake JE, Tseng CH, Currier JS. A pilot study of telmisartan for visceral adiposity in HIV infection: the metabolic abnormalities, telmisartan, and HIV infection (MATH) trial. PLoS One. 2013; 8(3):e58135. PMID: 23516440.
      View in: PubMed
    102. Kelesidis T, Yang OO, Kendall MA, Hodis HN, Currier JS. Dysfunctional HDL and progression of atherosclerosis in HIV-1-infected and -uninfected adults. Lipids Health Dis. 2013 Mar 05; 12:23. PMID: 23510548.
      View in: PubMed
    103. Kelesidis T, Kendall MA, Yang OO, Hodis H, Currier JS. Perturbations of circulating levels of RANKL-osteoprotegerin axis in relation to lipids and progression of atherosclerosis in HIV-infected and -uninfected adults: ACTG NWCS 332/A5078 Study. AIDS Res Hum Retroviruses. 2013 Jun; 29(6):938-48. PMID: 23351153.
      View in: PubMed
    104. Pilotto JH, Grinsztejn B, Veloso VG, Velasque LS, Friedman RK, Moreira RI, Rodrigues-Pedro A, Oliveira SM, Currier JS, Morgado MG. Moderate prevalence of transmitted drug resistance mutations among antiretroviral-naive HIV-infected pregnant women in Rio de Janeiro, Brazil. AIDS Res Hum Retroviruses. 2013 Apr; 29(4):681-6. PMID: 23259924.
      View in: PubMed
    105. Thio CL, Smeaton L, Saulynas M, Hwang H, Saravanan S, Saravan S, Kulkarni S, Hakim J, Nyirenda M, Iqbal HS, Lalloo UG, Mehta AS, Hollabaugh K, Campbell TB, Lockman S, Currier JS. Characterization of HIV-HBV coinfection in a multinational HIV-infected cohort. AIDS. 2013 Jan 14; 27(2):191-201. PMID: 23032418.
      View in: PubMed
    106. Kelesidis T, Kendall MA, Yang OO, Hodis HN, Currier JS. Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infection. J Infect Dis. 2012 Nov 15; 206(10):1558-67. PMID: 23066162.
      View in: PubMed
    107. Lake JE, McComsey GA, Hulgan TM, Wanke CA, Mangili A, Walmsley SL, Boger MS, Turner RR, McCreath HE, Currier JS. A randomized trial of Raltegravir replacement for protease inhibitor or non-nucleoside reverse transcriptase inhibitor in HIV-infected women with lipohypertrophy. AIDS Patient Care STDS. 2012 Sep; 26(9):532-40. PMID: 22823027.
      View in: PubMed
    108. Smith KY, Garcia F, Kumar P, Currier JS, Ryan R, Falcon R, Mrus J, Squires K. Assessing darunavir/ritonavir-based therapy in a racially diverse population: 48-week outcomes from GRACE. J Natl Med Assoc. 2012 Jul-Aug; 104(7-8):366-76. PMID: 23092052.
      View in: PubMed
    109. High KP, Brennan-Ing M, Clifford DB, Cohen MH, Currier J, Deeks SG, Deren S, Effros RB, Gebo K, Goronzy JJ, Justice AC, Landay A, Levin J, Miotti PG, Munk RJ, Nass H, Rinaldo CR, Shlipak MG, Tracy R, Valcour V, Vance DE, Walston JD, Volberding P. HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr. 2012 Jul 01; 60 Suppl 1:S1-18. PMID: 22688010.
      View in: PubMed
    110. Wilkin TJ, Lalama CM, McKinnon J, Gandhi RT, Lin N, Landay A, Ribaudo H, Fox L, Currier JS, Mellors JW, Gulick R, Tenorio AR. A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4? T-cell recovery despite sustained virologic suppression: ACTG A5256. J Infect Dis. 2012 Aug 15; 206(4):534-42. PMID: 22740718.
      View in: PubMed
    111. Lockman S, Hughes M, Sawe F, Zheng Y, McIntyre J, Chipato T, Asmelash A, Rassool M, Kimaiyo S, Shaffer D, Hosseinipour M, Mohapi L, Ssali F, Chibowa M, Amod F, Halvas E, Hogg E, Alston-Smith B, Smith L, Schooley R, Mellors J, Currier J. Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial. PLoS Med. 2012; 9(6):e1001236. PMID: 22719231.
      View in: PubMed
    112. Luetkemeyer AF, Havlir DV, Currier JS. Complications of HIV disease and antiretroviral therapy. Top Antivir Med. 2012 Jun-Jul; 20(2):48-60. PMID: 22710907.
      View in: PubMed
    113. Nielsen-Saines K, Komarow L, Cu-Uvin S, Jourdain G, Klingman KL, Shapiro DE, Mofenson L, Moran L, Campbell TB, Hitti J, Fiscus S, Currier J. Infant outcomes after maternal antiretroviral exposure in resource-limited settings. Pediatrics. 2012 Jun; 129(6):e1525-32. PMID: 22585772.
      View in: PubMed
    114. Kelesidis T, Humphries R, Terashita D, Eshaghian S, Territo MC, Said J, Lewinski M, Currier JS, Pegues D. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Los Angeles County. J Med Virol. 2012 May; 84(5):777-85. PMID: 22431026.
      View in: PubMed
    115. Dong BJ, Zheng Y, Hughes MD, Frymoyer A, Verotta D, Lizak P, Sawe F, Currier JS, Lockman S, Aweeka FT. Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women. AIDS. 2012 Apr 24; 26(7):833-41. PMID: 22301417.
      View in: PubMed
    116. Skinner-Adams TS, Butterworth AS, Porter KA, D'Amico R, Sawe F, Shaffer D, Siika A, Hosseinipour MC, Stringer E, Currier JS, Chipato T, Salata R, Lockman S, Eron JJ, Meshnick SR, McCarthy JS. The frequency of malaria is similar among women receiving either lopinavir/ritonavir or nevirapine-based antiretroviral treatment. PLoS One. 2012; 7(4):e34399. PMID: 22509297.
      View in: PubMed
    117. Porter KA, Cole SR, Eron JJ, Zheng Y, Hughes MD, Lockman S, Poole C, Skinner-Adams TS, Hosseinipour M, Shaffer D, D'Amico R, Sawe FK, Siika A, Stringer E, Currier JS, Chipato T, Salata R, McCarthy JS, Meshnick SR. HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 study. Antimicrob Agents Chemother. 2012 Feb; 56(2):995-1000. PMID: 22123685.
      View in: PubMed
    118. Kelesidis T, Currier JS, Huynh D, Meriwether D, Charles-Schoeman C, Reddy ST, Fogelman AM, Navab M, Yang OO. A biochemical fluorometric method for assessing the oxidative properties of HDL. J Lipid Res. 2011 Dec; 52(12):2341-51. PMID: 21957198.
      View in: PubMed
    119. Feinberg J, Saag M, Squires K, Currier J, Ryan R, Coate B, Mrus J. Health-related quality of life in the gender, race, and clinical experience trial. AIDS Res Treat. 2011; 2011:349165. PMID: 21904672.
      View in: PubMed
    120. Lake JE, Friedman RK, Cunha CB, Cardoso SW, Veloso VG, Currier JS, Grinsztejn B. Participation of women in HIV clinical trials: the IPEC-FIOCRUZ experience. HIV AIDS (Auckl). 2011; 3:61-8. PMID: 22096408.
      View in: PubMed
    121. Lake JE, Wohl D, Scherzer R, Grunfeld C, Tien PC, Sidney S, Currier JS. Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study. AIDS Care. 2011 Aug; 23(8):929-38. PMID: 21767228.
      View in: PubMed
    122. Falcon R, Bridge DA, Currier J, Squires K, Hagins D, Schaible D, Ryan R, Mrus J. Recruitment and retention of diverse populations in antiretroviral clinical trials: practical applications from the gender, race and clinical experience study. J Womens Health (Larchmt). 2011 Jul; 20(7):1043-50. PMID: 21663416.
      View in: PubMed
    123. Hoffman RM, Jamieson BD, Bosch RJ, Currier J, Kitchen CM, Schmid I, Zhu Y, Bennett K, Mitsuyasu R. Baseline immune phenotypes and CD4+ T lymphocyte responses to antiretroviral therapy in younger versus older HIV-infected individuals. J Clin Immunol. 2011 Oct; 31(5):873-81. PMID: 21643890.
      View in: PubMed
    124. Currier JS, Martorell C, Osiyemi O, Yin MT, Ryan R, De La Rosa G, Mrus J. Effects of darunavir/ritonavir-based therapy on metabolic and anthropometric parameters in women and men over 48 weeks. AIDS Patient Care STDS. 2011 Jun; 25(6):333-40. PMID: 21612545.
      View in: PubMed
    125. Cohn SE, Jiang H, McCutchan JA, Koletar SL, Murphy RL, Robertson KR, de St Maurice AM, Currier JS, Williams PL. Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362. AIDS Care. 2011 Jun; 23(6):775-85. PMID: 21293986.
      View in: PubMed
    126. Boltz VF, Zheng Y, Lockman S, Hong F, Halvas EK, McIntyre J, Currier JS, Chibowa MC, Kanyama C, Nair A, Owino-Ong'or W, Hughes M, Coffin JM, Mellors JW. Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine. Proc Natl Acad Sci U S A. 2011 May 31; 108(22):9202-7. PMID: 21576473.
      View in: PubMed
    127. Luetkemeyer AF, Havlir DV, Currier JS. Complications of HIV disease and antiretroviral therapy. Top Antivir Med. 2011 May-Jun; 19(2):58-68. PMID: 21868823.
      View in: PubMed
    128. Friedman RK, Bastos FI, Leite IC, Veloso VG, Moreira RI, Cardoso SW, Andrade AC, Sampaio MC, Currier J, Grinsztejn B. Pregnancy rates and predictors in women with HIV/AIDS in Rio de Janeiro, Southeastern Brazil. Rev Saude Publica. 2011 Apr; 45(2):373-81. PMID: 21412574.
      View in: PubMed
    129. Kelesidis T, Yang OO, Currier JS, Navab K, Fogelman AM, Navab M. HIV-1 infected patients with suppressed plasma viremia on treatment have pro-inflammatory HDL. Lipids Health Dis. 2011 Feb 23; 10:35. PMID: 21345230.
      View in: PubMed
    130. Ciaranello AL, Lockman S, Freedberg KA, Hughes M, Chu J, Currier J, Wood R, Holmes CB, Pillay S, Conradie F, McIntyre J, Losina E, Walensky RP. First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial. AIDS. 2011 Feb 20; 25(4):479-92. PMID: 21293199.
      View in: PubMed
    131. Umeh OC, Currier JS, Park JG, Cramer Y, Hermes AE, Fletcher CV. Sex differences in lopinavir and ritonavir pharmacokinetics among HIV-infected women and men. J Clin Pharmacol. 2011 Dec; 51(12):1665-73. PMID: 21233301.
      View in: PubMed
    132. Pilotto JH, Velasque LS, Friedman RK, Moreira RI, Veloso VG, Grinsztejn B, Morgado MG, Watts DH, Currier JS, Hoffman RM. Maternal outcomes after HAART for the prevention of mother-to-child transmission in HIV-infected women in Brazil. Antivir Ther. 2011; 16(3):349-56. PMID: 21555817.
      View in: PubMed
    133. Grinsztejn B, Smeaton L, Barnett R, Klingman K, Hakim J, Flanigan T, Kumarasamy N, Campbell T, Currier J. Sex-associated differences in pre-antiretroviral therapy plasma HIV-1 RNA in diverse areas of the world vary by CD4(+) T-cell count. Antivir Ther. 2011; 16(7):1057-62. PMID: 22024521.
      View in: PubMed
    134. Hammer SM, Ribaudo H, Bassett R, Mellors JW, Demeter LM, Coombs RW, Currier J, Morse GD, Gerber JG, Martinez AI, Spreen W, Fischl MA, Squires KE. A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimen. HIV Clin Trials. 2010 Nov-Dec; 11(6):312-24. PMID: 21239359.
      View in: PubMed
    135. Lake JE, Currier JS. Switching antiretroviral therapy to minimize metabolic complications. HIV Ther. 2010 Nov; 4(6):693-711. PMID: 22171239.
      View in: PubMed
    136. McComsey GA, Walker UA, Budhathoki CB, Su Z, Currier JS, Kosmiski L, Naini LG, Charles S, Medvik K, Aberg JA. Uridine supplementation in the treatment of HIV lipoatrophy: results of ACTG 5229. AIDS. 2010 Oct 23; 24(16):2507-15. PMID: 20827170.
      View in: PubMed
    137. Lockman S, Hughes MD, McIntyre J, Zheng Y, Chipato T, Conradie F, Sawe F, Asmelash A, Hosseinipour MC, Mohapi L, Stringer E, Mngqibisa R, Siika A, Atwine D, Hakim J, Shaffer D, Kanyama C, Wools-Kaloustian K, Salata RA, Hogg E, Alston-Smith B, Walawander A, Purcelle-Smith E, Eshleman S, Rooney J, Rahim S, Mellors JW, Schooley RT, Currier JS. Antiretroviral therapies in women after single-dose nevirapine exposure. N Engl J Med. 2010 Oct 14; 363(16):1499-509. PMID: 20942666.
      View in: PubMed
    138. Currier J, Averitt Bridge D, Hagins D, Zorrilla CD, Feinberg J, Ryan R, Falcon R, Tennenberg A, Mrus J, Squires K. Sex-based outcomes of darunavir-ritonavir therapy: a single-group trial. Ann Intern Med. 2010 Sep 21; 153(6):349-57. PMID: 20855799.
      View in: PubMed
    139. Delaney JA, Scherzer R, Biggs ML, Shliplak MG, Polak JF, Currier JS, Kronmal RA, Wanke C, Bacchetti P, O'leary D, Tien PC, Grunfeld C. Associations of antiretroviral drug use and HIV-specific risk factors with carotid intima-media thickness. AIDS. 2010 Sep 10; 24(14):2201-9. PMID: 20671544.
      View in: PubMed
    140. Hoffman RM, Black V, Technau K, van der Merwe KJ, Currier J, Coovadia A, Chersich M. Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2010 May 01; 54(1):35-41. PMID: 20216425.
      View in: PubMed
    141. Luetkemeyer AF, Havlir DV, Currier JS. Complications of HIV disease and antiretroviral treatment. Top HIV Med. 2010 Apr-May; 18(2):57-65. PMID: 20516525.
      View in: PubMed
    142. Currier J. Report from the 11th International Workshop on Adverse Drug Reactions and Co-morbidities in HIV. Treatment for patients with central fat accumulation. J Watch AIDS Clin Care. 2010 Mar; 22(3):21-2. PMID: 20480623.
      View in: PubMed
    143. Landovitz RJ, Currier JS. Clinical practice. Postexposure prophylaxis for HIV infection. N Engl J Med. 2009 Oct 29; 361(18):1768-75. PMID: 19864675.
      View in: PubMed
    144. Grunfeld C, Delaney JA, Wanke C, Currier JS, Scherzer R, Biggs ML, Tien PC, Shlipak MG, Sidney S, Polak JF, O'Leary D, Bacchetti P, Kronmal RA. Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study. AIDS. 2009 Sep 10; 23(14):1841-9. PMID: 19455012.
      View in: PubMed
    145. Aberg JA, Kaplan JE, Libman H, Emmanuel P, Anderson JR, Stone VE, Oleske JM, Currier JS, Gallant JE. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2009 Sep 01; 49(5):651-81. PMID: 19640227.
      View in: PubMed
    146. Currier JS. Update on cardiovascular complications in HIV infection. Top HIV Med. 2009 Jul-Aug; 17(3):98-103. PMID: 19675367.
      View in: PubMed
    147. Landovitz RJ, Combs KB, Currier JS. Availability of HIV postexposure prophylaxis services in Los Angeles County. Clin Infect Dis. 2009 Jun 01; 48(11):1624-7. PMID: 19400685.
      View in: PubMed
    148. Currier JS, Havlir DV. Complications of HIV disease and antiretroviral therapy. Top HIV Med. 2009 Apr-May; 17(2):57-67. PMID: 19401608.
      View in: PubMed
    149. Tsibris AM, Paredes R, Chadburn A, Su Z, Henrich TJ, Krambrink A, Hughes MD, Aberg JA, Currier JS, Tashima K, Godfrey C, Greaves W, Flexner C, Skolnik PR, Wilkin TJ, Gulick RM, Kuritzkes DR. Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211. Clin Infect Dis. 2009 Mar 01; 48(5):642-9. PMID: 19191652.
      View in: PubMed
    150. Volkmann ER, Claiborne D, Currier JS. Determinants of participation in HIV clinical trials: the importance of patients' trust in their provider. HIV Clin Trials. 2009 Mar-Apr; 10(2):104-9. PMID: 19487180.
      View in: PubMed
    151. Stein JH, Komarow L, Cotter BR, Currier JS, Dubé MP, Fichtenbaum CJ, Gerschenson M, Mitchell CK, Murphy RL, Squires K, Parker RA, Torriani FJ. Lipoprotein Changes in HIV-Infected Antiretroviral-Naïve Individuals after Starting Antiretroviral Therapy: ACTG Study A5152s Stein: Lipoprotein Changes on Antiretroviral Therapy. J Clin Lipidol. 2008 Dec; 2(6):464-471. PMID: 19956354.
      View in: PubMed
    152. Black V, Hoffman RM, Sugar CA, Menon P, Venter F, Currier JS, Rees H. Safety and efficacy of initiating highly active antiretroviral therapy in an integrated antenatal and HIV clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2008 Nov 01; 49(3):276-81. PMID: 18845949.
      View in: PubMed
    153. Torriani FJ, Komarow L, Parker RA, Cotter BR, Currier JS, Dubé MP, Fichtenbaum CJ, Gerschenson M, Mitchell CK, Murphy RL, Squires K, Stein JH. Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s. J Am Coll Cardiol. 2008 Aug 12; 52(7):569-76. PMID: 18687253.
      View in: PubMed
    154. Currier JS, Lundgren JD, Carr A, Klein D, Sabin CA, Sax PE, Schouten JT, Smieja M. Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy. Circulation. 2008 Jul 08; 118(2):e29-35. PMID: 18566319.
      View in: PubMed
    155. Grinspoon SK, Grunfeld C, Kotler DP, Currier JS, Lundgren JD, Dubé MP, Lipshultz SE, Hsue PY, Squires K, Schambelan M, Wilson PW, Yarasheski KE, Hadigan CM, Stein JH, Eckel RH. State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary. Circulation. 2008 Jul 08; 118(2):198-210. PMID: 18566320.
      View in: PubMed
    156. Micheletti RG, Fishbein GA, Currier JS, Singer EJ, Fishbein MC. Calcification of the internal elastic lamina of coronary arteries. Mod Pathol. 2008 Aug; 21(8):1019-28. PMID: 18536656.
      View in: PubMed
    157. Currier J, Scherzer R, Bacchetti P, Heymsfield S, Lee D, Sidney S, Tien PC. Regional adipose tissue and lipid and lipoprotein levels in HIV-infected women. J Acquir Immune Defic Syndr. 2008 May 01; 48(1):35-43. PMID: 18197118.
      View in: PubMed
    158. Currier JS, Lundgren JD. Guidelines for managing cardiovascular risk: an evolving area. Curr Opin HIV AIDS. 2008 May; 3(3):205-6. PMID: 19372967.
      View in: PubMed
    159. Stein JH, Currier JS. Risk of myocardial infarction and nucleoside analogues. Lancet. 2008 Apr 26; 371(9622):1391-2. PMID: 18387666.
      View in: PubMed
    160. Currier JS, Havlir DV. Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Complications of HIV disease and therapy. Top HIV Med. 2008 Apr-May; 16(1):23-30. PMID: 18441380.
      View in: PubMed
    161. Micheletti RG, Fishbein GA, Fishbein MC, Singer EJ, Weiss RE, Jeffries RA, Currier JS. Coronary atherosclerotic lesions in human immunodeficiency virus-infected patients: a histopathologic study. Cardiovasc Pathol. 2009 Jan-Feb; 18(1):28-36. PMID: 18402832.
      View in: PubMed
    162. Balamurugan A, Lewis MJ, Kitchen CM, Robertson MN, Shiver JW, Daar ES, Pitt J, Ali A, Ng HL, Currier JS, Yang OO. Primary human immunodeficiency virus type 1 (HIV-1) infection during HIV-1 Gag vaccination. J Virol. 2008 Mar; 82(6):2784-91. PMID: 18199650.
      View in: PubMed
    163. Currier J, Lazzarin A, Sloan L, Clumeck N, Slims J, McCarty D, Steel H, Kleim JP, Bonny T, Millard J. Antiviral activity and safety of aplaviroc with lamivudine/zidovudine in HIV-infected, therapy-naive patients: the ASCENT (CCR102881) study. Antivir Ther. 2008; 13(2):297-306. PMID: 18505181.
      View in: PubMed
    164. Tymchuk CN, Currier JS. The safety of antiretroviral drugs. Expert Opin Drug Saf. 2008 Jan; 7(1):1-4. PMID: 18171309.
      View in: PubMed
    165. Micheletti RG, Fishbein GA, Currier JS, Fishbein MC. Mönckeberg sclerosis revisited: a clarification of the histologic definition of Mönckeberg sclerosis. Arch Pathol Lab Med. 2008 Jan; 132(1):43-7. PMID: 18181672.
      View in: PubMed
    166. Hoffman RM, Umeh OC, Garris C, Givens N, Currier JS. Evaluation of sex differences of fosamprenavir (with and without ritonavir) in HIV-infected men and women. HIV Clin Trials. 2007 Nov-Dec; 8(6):371-80. PMID: 18042502.
      View in: PubMed
    167. Currier J. Report from the 9th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. AIDS Clin Care. 2007 Oct; 19(10):91. PMID: 18398999.
      View in: PubMed
    168. Fishbein GA, Micheletti RG, Currier JS, Singer E, Fishbein MC. Atherosclerotic oxalosis in coronary arteries. Cardiovasc Pathol. 2008 Mar-Apr; 17(2):117-23. PMID: 18329558.
      View in: PubMed
    169. Currier JS. Sex differences in antiretroviral therapy toxicity: lactic acidosis, stavudine, and women. Clin Infect Dis. 2007 Jul 15; 45(2):261-2. PMID: 17578789.
      View in: PubMed
    170. McCutchan JA, Wu JW, Robertson K, Koletar SL, Ellis RJ, Cohn S, Taylor M, Woods S, Heaton R, Currier J, Williams PL. HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. AIDS. 2007 May 31; 21(9):1109-17. PMID: 17502721.
      View in: PubMed
    171. Currier JS, Kendall MA, Henry WK, Alston-Smith B, Torriani FJ, Tebas P, Li Y, Hodis HN. Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults. AIDS. 2007 May 31; 21(9):1137-45. PMID: 17502724.
      View in: PubMed
    172. Currier J. Report from the 14th Retrovirus Conference. Metabolic complications: lipoatrophy, lipohypertrophy, and cardiovascular risk. AIDS Clin Care. 2007 May; 19(5):40-1. PMID: 18398989.
      View in: PubMed
    173. Currier JS, Havlir DV. Complications of HIV disease and therapy. Top HIV Med. 2007 Apr-May; 15(2):40-7. PMID: 17485786.
      View in: PubMed
    174. Hoffman RM, Currier JS. Management of antiretroviral treatment-related complications. Infect Dis Clin North Am. 2007 Mar; 21(1):103-32, ix. PMID: 17502232.
      View in: PubMed
    175. Currier JS, Baden LR. Getting smarter--the toxicity of undertreated HIV infection. N Engl J Med. 2006 Nov 30; 355(22):2359-61. PMID: 17135590.
      View in: PubMed
    176. Grinsztejn B, Bastos FI, Veloso VG, Friedman RK, Pilotto JH, Schechter M, Derrico M, Andrade A, Lourenço MC, Moreira RI, Russomano F, Morgado M, Currier JS. Assessing sexually transmitted infections in a cohort of women living with HIV/AIDS, in Rio de Janeiro, Brazil. Int J STD AIDS. 2006 Jul; 17(7):473-8. PMID: 16820078.
      View in: PubMed
    177. Umeh OC, Currier JS. Sex differences in pharmacokinetics and toxicity of antiretroviral therapy. Expert Opin Drug Metab Toxicol. 2006 Apr; 2(2):273-83. PMID: 16866613.
      View in: PubMed
    178. Currier J. Report from the 13th retrovirus conference. Metabolic complications and cardiovascular disease. AIDS Clin Care. 2006 Apr; 18(4):36-7. PMID: 16718880.
      View in: PubMed
    179. Havlir DV, Currier JS. Complications of HIV disease and antiretroviral therapy. Top HIV Med. 2006 Mar-Apr; 14(1):27-35. PMID: 16641525.
      View in: PubMed
    180. Currier JS, Kendall MA, Henry WK, Torriani FJ, Hodis HN. Response to: 'carotid intima-media thickness: assessment of sub-clinical atherosclerosis in HIV-infected patients'. AIDS. 2006 Jan 09; 20(2):311. PMID: 16511437.
      View in: PubMed
    181. Currier J. Report from the 7th International Lipodystrophy Meeting. AIDS Clin Care. 2006 Jan; 18(1):11-2. PMID: 16555403.
      View in: PubMed
    182. Currier J. Meeting notes from the 3rd IAS Conference. HIV treatment and risk for metabolic complications. AIDS Clin Care. 2005 Oct; 17(10):95-6. PMID: 16276590.
      View in: PubMed
    183. Umeh OC, Currier JS. Lipids, metabolic syndrome, and risk factors for future cardiovascular disease among HIV-infected patients. Curr HIV/AIDS Rep. 2005 Aug; 2(3):132-9. PMID: 16091260.
      View in: PubMed
    184. Currier JS, Kendall MA, Zackin R, Henry WK, Alston-Smith B, Torriani FJ, Schouten J, Mickelberg K, Li Y, Hodis HN. Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure. AIDS. 2005 Jun 10; 19(9):927-33. PMID: 15905673.
      View in: PubMed
    185. Mulligan K, Zackin R, Clark RA, Alston-Smith B, Liu T, Sattler FR, Delvers TB, Currier JS. Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial. Arch Intern Med. 2005 Mar 14; 165(5):578-85. PMID: 15767536.
      View in: PubMed
    186. Currier JS, Havlir DV. Complications of HIV disease and antiretroviral therapy. Top HIV Med. 2005 Mar-Apr; 13(1):16-23. PMID: 15849369.
      View in: PubMed
    187. Umeh OC, Currier JS. Sex Differences in HIV: Natural History, Pharmacokinetics, and Drug Toxicity. Curr Infect Dis Rep. 2005 Jan; 7(1):73-78. PMID: 15610674.
      View in: PubMed
    188. Henry K, Kitch D, Dube M, Zackin R, Parker RA, Sprecher D, Hammer S, Currier J. C-Reactive protein levels over time and cardiovascular risk in HIV-infected individuals suppressed on an indinavir-based regimen: AIDS Clinical Trials Group 5056s. AIDS. 2004 Dec 03; 18(18):2434-7. PMID: 15622323.
      View in: PubMed
    189. Solorio MR, Currier J, Cunningham W. HIV health care services for Mexican migrants. J Acquir Immune Defic Syndr. 2004 Nov 01; 37 Suppl 4:S240-51. PMID: 15722866.
      View in: PubMed
    190. Koletar SL, Williams PL, Wu J, McCutchan JA, Cohn SE, Murphy RL, Lederman HM, Currier JS. Long-term follow-up of HIV-infected individuals who have significant increases in CD4+ cell counts during antiretroviral therapy. Clin Infect Dis. 2004 Nov 15; 39(10):1500-6. PMID: 15546087.
      View in: PubMed
    191. Yasuda JM, Miller C, Currier JS, Forthal DN, Kemper CA, Beall GN, Tilles JG, Capparelli EV, McCutchan JA, Haubrich RH. The correlation between plasma concentrations of protease inhibitors, medication adherence and virological outcome in HIV-infected patients. Antivir Ther. 2004 Oct; 9(5):753-61. PMID: 15535413.
      View in: PubMed
    192. Currier J. Meeting report from the XV International AIDS Conference. Metabolic complications. AIDS Clin Care. 2004 Sep; 16(9):73-4. PMID: 15540318.
      View in: PubMed
    193. Aberg JA, Gallant JE, Anderson J, Oleske JM, Libman H, Currier JS, Stone VE, Kaplan JE. Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2004 Sep 01; 39(5):609-29. PMID: 15356773.
      View in: PubMed
    194. Currier J. Report from the 11th conference on retroviruses and opportunistic infections. Metabolic complications. AIDS Clin Care. 2004 Apr; 16(4):29-32. PMID: 15124585.
      View in: PubMed
    195. Currier J. Report from the 11th conference on retroviruses and opportunistic infections. Neurology of HIV. AIDS Clin Care. 2004 Apr; 16(4):33-4. PMID: 15124587.
      View in: PubMed
    196. Currier JS, Havlir DV. Complications of HIV disease and antiretroviral therapy. Highlights of the 11th Conference on Retroviruses and Opportunistic Infections, February 8-11, 2004, San Francisco, California, USA. Top HIV Med. 2004 Mar-Apr; 12(1):31-45. PMID: 15111728.
      View in: PubMed
    197. Lederman HM, Williams PL, Wu JW, Evans TG, Cohn SE, McCutchan JA, Koletar SL, Hafner R, Connick E, Valentine FT, McElrath MJ, Roberts NJ, Currier JS. Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion. J Infect Dis. 2003 Dec 15; 188(12):1794-803. PMID: 14673757.
      View in: PubMed
    198. Hammer SM, Bassett R, Squires KE, Fischl MA, Demeter LM, Currier JS, Mellors JW, Morse GD, Eron JJ, Santana JL, DeGruttola V. A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir. Antivir Ther. 2003 Dec; 8(6):507-18. PMID: 14760884.
      View in: PubMed
    199. Benson CA, Williams PL, Currier JS, Holland F, Mahon LF, MacGregor RR, Inderlied CB, Flexner C, Neidig J, Chaisson R, Notario GF, Hafner R. A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome. Clin Infect Dis. 2003 Nov 01; 37(9):1234-43. PMID: 14557969.
      View in: PubMed
    200. Dubé MP, Stein JH, Aberg JA, Fichtenbaum CJ, Gerber JG, Tashima KT, Henry WK, Currier JS, Sprecher D, Glesby MJ. Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. Clin Infect Dis. 2003 Sep 01; 37(5):613-27. PMID: 12942391.
      View in: PubMed
    201. Currier JS, Taylor A, Boyd F, Dezii CM, Kawabata H, Burtcel B, Maa JF, Hodder S. Coronary heart disease in HIV-infected individuals. J Acquir Immune Defic Syndr. 2003 Aug 01; 33(4):506-12. PMID: 12869840.
      View in: PubMed
    202. Hicks C, Currier J, Sax P, Sherer R, Wanke C. Current management challenges in HIV: tolerability of antiretrovirals and metabolic complications. AIDS Patient Care STDS. 2003 May; 17(5):221-33. PMID: 12816616.
      View in: PubMed
    203. Havlir DV, Currier JS. Complications of HIV infection and antiretroviral therapy. Top HIV Med. 2003 May-Jun; 11(3):86-91. PMID: 12837967.
      View in: PubMed
    204. Currier J. Report from the Tenth Retrovirus Conference. Metabolic complications. AIDS Clin Care. 2003 Apr; 15(4):36-7. PMID: 12712954.
      View in: PubMed
    205. Aberg JA, Williams PL, Liu T, Lederman HM, Hafner R, Torriani FJ, Lennox JL, Dube MP, MacGregor RR, Currier JS. A study of discontinuing maintenance therapy in human immunodeficiency virus-infected subjects with disseminated Mycobacterium avium complex: AIDS Clinical Trial Group 393 Study Team. J Infect Dis. 2003 Apr 01; 187(7):1046-52. PMID: 12660918.
      View in: PubMed
    206. Hamzeh FM, Benson C, Gerber J, Currier J, McCrea J, Deutsch P, Ruan P, Wu H, Lee J, Flexner C. Steady-state pharmacokinetic interaction of modified-dose indinavir and rifabutin. Clin Pharmacol Ther. 2003 Mar; 73(3):159-69. PMID: 12621381.
      View in: PubMed
    207. Kuritzkes DR, Currier J. Cardiovascular risk factors and antiretroviral therapy. N Engl J Med. 2003 Feb 20; 348(8):679-80. PMID: 12594310.
      View in: PubMed
    208. Wohl AR, Johnson DF, Lu S, Jordan W, Beall G, Currier J, Simon PA. HIV risk behaviors among African American men in Los Angeles County who self-identify as heterosexual. J Acquir Immune Defic Syndr. 2002 Nov 01; 31(3):354-60. PMID: 12439213.
      View in: PubMed
    209. Schambelan M, Benson CA, Carr A, Currier JS, Dubé MP, Gerber JG, Grinspoon SK, Grunfeld C, Kotler DP, Mulligan K, Powderly WG, Saag MS. Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel. J Acquir Immune Defic Syndr. 2002 Nov 01; 31(3):257-75. PMID: 12439201.
      View in: PubMed
    210. Currier JS. HIV Infection in Women: Selected Issues in Pregnancy. Top HIV Med. 2002 Nov-Dec; 10(5):16-20. PMID: 12717051.
      View in: PubMed
    211. Currier JS. Cardiovascular risk associated with HIV therapy. J Acquir Immune Defic Syndr. 2002 Sep 01; 31 Suppl 1:S16-23; discussion S24-5. PMID: 12218440.
      View in: PubMed
    212. Abdool Karim SS, Currier J, del Rio C, Feinberg J, Friedland GH, Sax PE, Zuger A. Report on the XIV International AIDS Conference. AIDS Clin Care. 2002 Sep; 14(9):77-85. PMID: 12236208.
      View in: PubMed
    213. Aberg JA, Chin-Hong PV, McCutchan A, Koletar SL, Currier JS. Localized osteomyelitis due to Mycobacterium avium complex in patients with Human Immunodeficiency Virus receiving highly active antiretroviral therapy. Clin Infect Dis. 2002 Jul 01; 35(1):E8-E13. PMID: 12060894.
      View in: PubMed
    214. Cohn SE, Kammann E, Williams P, Currier JS, Chesney MA. Association of adherence to Mycobacterium avium complex prophylaxis and antiretroviral therapy with clinical outcomes in Acquired Immunodeficiency Syndrome. Clin Infect Dis. 2002 Apr 15; 34(8):1129-36. PMID: 11915003.
      View in: PubMed
    215. Currier J, Carpenter C, Daar E, Kotler D, Wanke C. Identifying and managing morphologic complications of HIV and HAART. AIDS Read. 2002 Mar; 12(3):114-9, 124-5. PMID: 11966241.
      View in: PubMed
    216. Currier J. Metabolic complications of HIV infection: translating research findings into clinical practice. AIDS Clin Care. 2002 Jan; 14(1):1-2, 8. PMID: 11802627.
      View in: PubMed
    217. Currier J. Management of metabolic complications of therapy. AIDS. 2002; 16 Suppl 4:S171-6. PMID: 12699014.
      View in: PubMed
    218. Currier JS, Williams P, Feinberg J, Becker S, Owens S, Fichtenbaum C, Benson C. Impact of prophylaxis for Mycobacterium avium complex on bacterial infections in patients with advanced human immunodeficiency virus disease. Clin Infect Dis. 2001 Jun 01; 32(11):1615-22. PMID: 11340534.
      View in: PubMed
    219. Currier JS, Williams PL, Koletar SL, Cohn SE, Murphy RL, Heald AE, Hafner R, Bassily EL, Lederman HM, Knirsch C, Benson CA, Valdez H, Aberg JA, McCutchan JA. Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team. Ann Intern Med. 2000 Oct 03; 133(7):493-503. PMID: 11015162.
      View in: PubMed
    220. Currier JS, Spino C, Grimes J, Wofsy CB, Katzenstein DA, Hughes MD, Hammer SM, Cotton DJ. Differences between women and men in adverse events and CD4+ responses to nucleoside analogue therapy for HIV infection. The Aids Clinical Trials Group 175 Team. J Acquir Immune Defic Syndr. 2000 Aug 01; 24(4):316-24. PMID: 11015147.
      View in: PubMed
    221. Currier JS. Discontinuing prophylaxis for opportunistic infection: guiding principles. Clin Infect Dis. 2000 Apr; 30 Suppl 1:S66-71. PMID: 10770914.
      View in: PubMed